Factor XIa inhibitor (BMS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFactor XIa inhibitor (BMS)
Drug Alias Nameoral Factor XIa inhibitor (Bristol-Myers Squibb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A